Sulfamide

Sulfamide

SCHEMBL6420737

NS(N)(=O)=O.O=C(Cc1ccccc1)c1cccs1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.53
NPC1 O15118 3/20 0.53
ALDH1A1 P00352 3/20 0.53
RAB9A P51151 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LMNA P02545 1/20 0.53
HPGD P15428 6/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KDM4E B2RXH2 2/20 0.50
GSK3B P49841 1/20 0.50
ERCC5 P28715 1/20 0.50
FEN1 P39748 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1515726 0.92 NPC1 (0.62) POLBNPC1ALDH1A1RAB9AMEN1
Bromobenzene SCHEMBL5171768 0.84 L3MBTL1 (0.54) POLBNPC1ALDH1A1RAB9AMEN1
SCHEMBL18437367 0.78 ALDH1A1 (0.58) POLBNPC1ALDH1A1RAB9AMEN1
SCHEMBL11267020 0.77 NPC1 (0.57) POLBNPC1ALDH1A1RAB9AMEN1
SCHEMBL9048735 0.77 POLB (0.61) POLBNPC1ALDH1A1RAB9AMEN1
SCHEMBL27931472 0.76 ALDH1A1 (0.51) POLBNPC1ALDH1A1RAB9AMEN1
SCHEMBL251992 0.75 NPC1 (0.69) POLBNPC1ALDH1A1RAB9AMEN1
SCHEMBL6421620 0.73 MAPK8 (0.48) NPC1ALDH1A1RAB9AMEN1KMT2A
SCHEMBL7038772 0.73 MEN1 (0.64) POLBNPC1ALDH1A1RAB9AMEN1
SCHEMBL1436692 0.73 ALDH1A1 (0.51) POLBNPC1ALDH1A1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0980369-B1 SULFONAMIDES FOR TREATMENT OF ENDOTHELIN-MEDIATED DISORDERS ENCYSIVE PHARMACEUTICALS INC (US) 2005-03-30 EP claimed